NVHR in the News

Share this

2020 News Stories

We Can’t Eliminate Hepatitis C Without Removing Barriers to Treatment - Nov. 14, 2020 

To progress toward eliminating this disabling and deadly disease, the U.S. must eliminate Medicaid restrictions on hepatitis C treatment and educate providers about ongoing stigma that disenfranchises certain communities.



State Policies Create Barriers to Hepatitis C Elimination - Nov. 13, 2020

Requiring sobriety prior to treatment and curtailing harm reduction hinder efforts to eliminate hep C.



Consider the Unintended Consequences on Patient Care - Oct. 15, 2020

NVHR's Adrienne Simmons was published in Hep Magazine advocating for CMS to delay a proposed Medicaid rule change that could negatively impact hepatitis patients.



New State Regulations Expand Access to Hepatitis C Treatments - Oct. 8, 2020

Dr. Adrienne Simmons, Pharmacist and Policy Manager at the National Viral Hepatitis Roundtable and Annette Gaudino, Director of Policy Strategy at the Treatment Action Group speak with WCNY's Capitol Pressroom about the removal of prior authorization requirements for hepatitis C treatment for NY Medicaid beneficiaries. Listen here.



NVHR and HEP Statement on Systemic Racism and Inequalities Facing Black Communities - June 3, 2020



Opinion: Hepatitis C is a curable disease. Texans shouldn’t have to wait for a cure Statesmen, March 7, 2020




“It's Destroyed People's Lives”: The Shocking Rise in Hepatitis C-Related DeathsBroadly, June 16, 2016

Report: Number of hepatitis C-linked deaths at record highPocono Record, May 18, 2016

It’s Time to End Insurance Restrictions on Life-Saving Hepatitis C Treatments, American Journal of Managed Care, May 3, 2016

Hepatitis C drug costs leave many without care, Boston Globe, April 9, 2016

The Link Between Hepatitis B, C, and Cancer, MediaPlanet, March 29, 2015

President's federal budget sustains HIV funding, viral hepatitis funding falls flatThe Bay Area Reporter, February 18, 2016




State Medicaid Restrictions for Hepatitis C Cures Are Creating One of America's Worst Health DisparitiesHuffington Post, December 11, 2015

Gilead expands PrEP assistance; feds call for more hep C coverageThe Bay Area Reporter, November 26, 2015

Hep C: Why doctors say all baby boomers should be testedChicago Tribune, October 8, 2015

White House Is Pressed to Help Widen Access to Hepatitis C Drugs via Medicaid, The New York Times, August 25, 2015

A Time to Cure: The Growing Case for New Hepatitis C TreatmentsHuffington Post, August 13, 2015

The Past, Present and Future of Hepatitis CUSA Today, September 23, 2015

Discourse needed on 'culturally invisible' diseaseBloomington Herald-Times, August 19, 2015

Specialty Drug Costs: Hard Pills to SwallowWorkforce, May 24, 2015

Resolved For 2015: No More Hepatitis CHuffington Post, January 8, 2015




One company’s battle to stop the wave of high-priced drugsThe Washington Post, December 24, 2014

Hepatitis C: The cost conundrumThe Hill, November 12, 2014

Hepatitis C patients may not qualify for pricey drugs unless illness is advancedThe Washington Post, November 4, 2014

Some Hep C Patients May Not Get Coverage for Pricey DrugsMedPage Today, October 28, 2014

Harvoni, a Hepatitis C Drug From Gilead, Wins F.D.A. ApprovalNew York Times, October 10, 2014

Why Hepatitis C Still Kills 16,000 Americans Per Year, and What We Can Do About ItHuffington Post, July 28, 2014

States limit Medicaid users’ access to hepatitis drug because of costDelaware Online, July 28, 2014

Sovaldi Debate Continues: Will Medicaid And Insurance Companies Approve This High Cost Cure For Hepatitis C Patients?,Medical Daily, July 24, 2014

Patient Cures Spur Demand for $1,000 Hepatitis C PillBloomberg, July 24, 2014

New hepatitis C drugs’ price prompts an ethical debate: Who deserves to get them?The Washington Post, May 2, 2014

Medicare Eases Restrictions On Pricey Hepatitis C TreatmentNPR, May 16, 2014

Medicare Won't Always Pay For Boomers' Pricey Hepatitis C Drugs, NPR, May 12, 2014

Healthier Patients May Have To Wait For Costly Hepatitis C DrugsNPR, May 12, 2014

Costly hepatitis C drug worries insurers, patients, Tampa Bay Times, March 23, 2014